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  Flow  cytometry  was  used  to  identify  and  characterize 
monoclonal  antibodies  (mAbs)  that  react  with  rabbit 
leukocyte differentiation molecules (LDM). Screening sets 
of  mAbs,  developed  against  LDM  in  other  species,  for 
r e a c t i v i t y  w i t h  r a b b i t  L D M  y i e l d e d  1 1  m A b s  t h a t  
recognize conserved epitopes on rabbit LDM orthologues 
and multiple mAbs that recognize epitopes expressed on 
the major histocompatibility class I or class II molecules. 
Screening of mAbs submitted to the Animal Homologues 
Section  of  the  Eighth  Human  Leukocyte  Differentiation 
Workshop yielded 7 additional mAbs. Screening of mAbs 
generated  from  mice  immunized  with  leukocytes  from 
rabbit  thymus  or  spleen  or  concanavalin  A  activated 
peripheral blood and/or spleen lymphocytes has yielded 42 
mAbs that recognize species restricted epitopes expressed 
on one or more lineages of leukocytes. Screening of the 
anti-rabbit  mAbs  against  leukocytes  from  other  species 
yielded one additional mAb. The studies show that screening 
of existing sets of mAbs for reactivity with rabbit LDM 
will not be productive and that a direct approach will be 
needed to develop mAbs for research in rabbits. The flow 
cytometric approach we developed to screen for mAbs of 
interest offers a way for individual laboratories to identify 
and  characterize  mAbs  to  LDM  in  rabbits  and  other 
species.  A  web-based  program  we  developed  provides  a 
source  of  information  that  will  facilitate  analysis.  It 
contains a searchable data base on known CD molecules 
and a data base on mAbs, known to react with LDM in 
one  or  more  species  of  artiodactyla,  equidae,  carnivora, 
and or lagomorpha.
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antibodies, rabbit
Introduction 
  Over the past years, development and characterization of 
mAbs developed against leukocyte differentiation mole-
cules (LDM) in humans has been facilitated by the con-
vening of international workshops to compare the reactivity 
of mAbs developed in different laboratories [66]. Similar 
workshops have been convened for characterization of 
mAbs to LDM in ruminants [29,30,46], pigs [23,38,52,55], 
horses [33,36], and dogs [8]. However, progress has been 
much slower owing to limited number of laboratories 
participating in the workshops and the smaller number of 
mAbs submitted for analysis. In effort to accelerate identifica-
tion of important mAbs, investigators have explored the 
possibility that many of the well characterized mAbs to 
human LDM might recognize epitopes conserved on 
orthologous LDM in other species. Although some useful 
cross reactive mAbs have been identified [56-58], recent 
results from analysis of a large set of anti-human LDM 
mAbs submitted to the Animal Homologues Section of the 
eighth human LDM workshop [54] and results reported in 
the ruminant and pig workshops [29,30,46,56-58] have 
shown the probability of finding a mAb that recognizes an 
epitope conserved on orthologous LDM is greater between 
closely related species than between distantly related species 
[4] for example, between cattle, bison, water buffalo, Cape 
buffalo, goats, sheep, and camelids [28,44,45,47,61]. The 
most successful approach for identifying mAbs to LDM in 
the species of interest has remained a focused effort on 
developing mAbs to LDM in that species, taking advan-
tage of cross reactive mAbs whenever they are found to 
facilitate characterization of new mAbs [14]. 
  The rabbit is an example of a species where there is a 
critical need for mAb reagents (NCBI Rabbit Genome 
Resources, USA). To date, however, only a few mAbs have 
been developed to meet this need. Efforts to expand the 
available sets of mAbs with cross reactive mAbs generated 
against LDM in other species has only yielded a few mAbs. 
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mAbs submitted to the Animal Homologues Section of the 
HLDA8 have been specific for major histocompatibility 
(MHC) I and II molecules, CD7, CD9, CD14, CD21, 
CD11a, CD18, CD44, CD45RB, CD49d, CD209 [54]. In 
light of these findings, it is apparent that a more direct 
approach will be required to identify mAbs for research in 
rabbits. As part of our continued effort to develop mAbs 
critical to our research efforts in ruminants, we have de-
veloped a flow cytometric approach for initial identifica-
tion and characterization of mAbs to LDM [11]. Previous 
studies have shown that two parameter single fluorescence 
flow cytometry can be used to cluster mAb that recognize 
the same or different epitopes on the same LDM, based on 
the pattern of expression of the molecule on one or more 
lineages of leukocytes [11,16,35]. Comparative studies 
have shown this method can also be used to identify and 
tentatively cluster mAbs that recognize epitopes on 
orthologous LDM based on the similarity of the pattern of 
expression of the LDM on leukocytes in different species. 
Our studies have revealed the pattern of expression of 
many orthologous LDM has been conserved cross species. 
This observation has proven useful, especially in the 
characterization of mAbs specific for LDM in less well 
studied species [13-15,59,60]. It has also proven useful in 
determining whether mAbs that cross react with LDM in 
one or more species recognize an epitope conserved on 
bona fide LDM orthologues. Specificity has also been 
documented by cloning and expression of LDM initially 
identified with cross reactive mAbs [59]. To aid others as 
well as ourselves, we have also developed a web based 
program, the Taxonomic Key Program (TKP; College of 
Veterinary Medicine, Washington State University, USA), 
to facilitate characterization of mAbs generated against 
LDM in less well studied species. The program contains a 
searchable database on known CD molecules and a data-
base containing a catalog of mAbs known to react with 
LDM in one or more of the less well studied species. In the 
present report we summarize the results we have obtained 
thus far, in our efforts to develop mAbs for use in immu-
nological investigations in the rabbit. Information on the 
mAbs recognizing rabbit LDMs are listed under reactivity 
of antibodies in the TKP program (NCBI Rabbit Genome 
Resources, USA).
Materials and Methods 
Animals
  Rabbits being used in other studies were used as a source 
of blood and tissues. They were housed and maintained 
according to the Institutional Animal Care and Use com-
mittee guidelines and Association for Assessment and 
Accreditation of Laboratory Animal Care (USA). Both 
male and female rabbits were used since initial studies did 
not reveal any apparent differences in the frequency of 
leukocyte subsets. The age of the rabbits varied from six 
months to about two years.
Preparation of leukocytes for flow cytometry
  Because of the tendency for T lymphocytes to bind to 
erythrocytes, separation medium could not be used to isolate 
leukocytes. Whole blood, collected in anti- coagulant citrate- 
dextrose (ACD), was used with a fix-lyse solution to obtain 
leukocytes for analysis. For single color flow cytometry 
(FC), 50 µl of blood was distributed in conical bottom 
96-well microtiter plates (Corning, USA) containing 50 µl 
of optimally diluted mouse mAbs and then incubated for 15 
min on ice. Following centrifugation, the supernatants were 
removed by aspiration. The lymphocytes were subjected to 3 
cycles of centrifugation and washing in FC first wash 
buffer (FWB, PBS co ntaining 20% ACD and 0.5% horse 
serum) and then incubated with a second step fluorescein 
conjugated polyclonal goat anti-mouse IgG/IgM second 
step reagent (Caltag Laboratories, USA) for an additional 
15 min. Following 2 cycles of centrifugation and washing 
in FC second wash buffer (PBS-20% ACD) the lymphocytes 
were resuspended in FACS lysing solution (Becton 
Dickinson, USA) to lyse erythrocytes. The lymphocytes 
were then centrifuged and resuspended in 2% PBS- 
buffered formaldehyde and kept in the refrigerator until 
examined. For multi-color FC, blood was distributed in 
microtiter plates containing 2 or 3 mAbs and incubated as 
described. Following centrifugation and 3 cycles of washing, 
the lymphocytes were incubated with second step reagents. 
For most of the studies, combinations of mAbs of different 
isotype were used with isotype specific goat anti-mouse 
immunoglobulins conjugated with fluorescein (FL), phycoery-
thrin (PE), PE-Cy5, or Cy5 (Caltag Laboratories, USA). 
Where the mAbs of interest were the same isotype, Zenon 
Fab fragments of goat isotype specific anti-mouse antibody, 
conjugated with different fluorochromes, were used according 
to the manufacturers' instructions (Invitrogen, USA). One 
µg of each mAb in 20 µl of FWB were incubated separately 
with 5 µl of Zenon-Fab reagent conjugated with different 
fluorochromes (FL, PE, PE-Cy5, or Cy5) for 5 min at room 
temperature as recommended by the manufacturers. The 
mixtures were then incubated with 5 µl of blocking reagent 
(mouse immunoglobulin) for an additional 5 min. The 
labeled antibodies were then added to the lymphocyte 
preparations under study. Following 15 min of incubation 
on ice, the lymphocytes were processed as described and 
fixed in 2% buffered formaldehyde.
  Peripheral blood mononuclear lymphocytes (PBMC) and 
spleen lymphocytes stimulated with concanavalin A 
(ConA) were used for immunization and identification of 
mAbs that recognize molecules upregulated on activated 
lymphocytes (rabbit activation molecules, RACT). To 
simplify initial screening of supernatants from primary 
cultures of hybridomas for the presence of a mAb that Monoclonal antibodies specific for rabbit leukocyte differentiation molecules    53
recognizes a RACT, spleen lymphocytes stimulated with 
ConA (5 µg/ml) for 24 to 48 h were incubated with 
hydroethidine (250 µg/ml in tissue culture medium), a vital 
dye that is selectively taken up by live cells. Hydroethidine 
(Polysciences, USA) intercalates into DNA similar to 
propidium iodide. It is excited at 488 nm and emits at high 
wave lengths (580 nm and higher). Following 8 min 
incubation at 37
oC, the cells were subjected to 2 cycles of 
washing by centrifugation and re-suspension in medium 
and then added to an equivalent concentration of unstimu-
lated cells. The mixed populations of cells were then 
incubated with tissue culture supernatants on ice as described 
and prepared for FC. Screening was performed with live 
cells immediately after labeling.
  For further analysis of the pattern of expression of mAb- 
defined LDM, cells were obtained from thymus, spleen, 
and appendix at the time of necropsy. Cells from the 
respective tissues were isolated by mincing the tissues with 
a scissors and then passing the tissue preparation through a 
100 mesh stainless steel sieve and suspended in PBS. Cells 
were used immediately or cryopreserved for later use. For 
cryopreservation, 10
7 to 10
8 cells were resuspended in 
bovine calf serum containing 10% DMSO and kept in a 
liquid nitrogen freezer.
Development of mAbs to rabbit LDM
  Five fusions were made with groups of 5 mice hyper- 
immunized with thymus (RT and RTH), ConA stimulated 
spleen cells (ISC), resting and ConA stimulated spleen and 
PBMC (MRB), or ConA stimulated PBMC (RACT) as 
previously described [22]. The general protocol was to 
immunize mice 5 times subcutaneously with ∼5 × 10
6 cells 
per mouse. Seventy two hours before fusion, mice were 
injected i.v. through the tail vein with approximately 3 × 
10
6 cells. After 72 h, spleen cells were harvested and 
pooled. 10
8 lymphocytes were fused with 4 × 10
7 X63 
myeloma cells as previously described [22] and then 
distributed into ten 96 well culture plates. The rest of the 
lymphocytes were cryopreserved for use in additional 
fusions. At 8 days, supernatants were collected and 
screened by FC for the presence of antibody, using blood or 
unstimulated and ConA stimulated spleen cells as described 
above.
  Supernatants from primary cultures of hybridomas were 
screened for the presence of mAb specific for LDM using 
FC with whole blood. Positive cultures were expanded in 
12 well culture plates. Supernatants were collected for 
further analysis and the cells cryopreserved. Since there 
was limited information on the pattern of reactivity of 
known LDM expressed on rabbit leukocytes, all hybrid-
omas producing mAb were cryopreserved. This included 
hybridomas identified in screening experiments where 
hydroethidine was used to identify hybridomas producing 
mAbs to activation molecules.
Antibodies
  Cross reactive and new mAbs developed in our laboratory 
are shown in Table 1. mAbs specific for CD4 (Ken4) [31], 
CD11b (mAb 198) [65], CD11c (mAb 3/22, no longer 
listed by AbD Serotec [NC]), CD45 (mAb L12/201) [65], 
CD58 (VC21) [64] were purchased from AbD Serotec 
(USA). A mAb thought to react with rabbit CD5 (Ken5; 
BioSource, USA) [31]. CD8 (12.C7) [18] was purchased 
from Abcam (USA). mAbs specific for CD11a (Ken11) 
[31] and CD25 (Kei-α1) [32] were purchased from BD 
Pharmingen (USA). Fluorescein conjugated anti-rabbit Ig 
was purchased from Zymed (USA).
Clustering and Characterization of mAbs
  All hybridomas producing mAbs to LDM expressed on 
lymphocytes or granulocytes were cloned. Hybridomas 
producing mAbs to LDM expressed on multiple lineages of 
leukocytes were first clustered based on the unique patterns 
of expression of the molecule on leukocytes, as detected by 
2 parameter FC (SSC vs fluorescence). Two or three hybri-
domas were selected from each distinct cluster for cloning 
and further analysis. Hybridomas producing mAbs that 
yielded profiles similar to MHC class I and II molecules 
were set aside for later analysis. For further characterization, 
FC dot plot profiles of whole blood preparations of 
leukocytes labeled with new mAbs were compared to each 
other and with profiles obtained with the cross reactive 
mAbs or commercially available mAbs specific for rabbit 
LDM. Two color FC analysis was performed to determine 
whether mAbs in a cluster recognized the same or different 
molecules. Two mAbs were considered to recognize the 
same molecule if one of the mAb blocked labeling by the 
other or if the mAbs being compared yielded a diagonal 
pattern of labeling [11,34,35]. Pairs of mAbs yielding a 
diffuse pattern of labeling were considered to recognize 
different molecules on the same population of lymphocytes.
Flow cytometry
    A Becton Dickinson FACSort equipped with a MAC 
computer and Cell Quest software (BD Immunocytometry 
Systems, USA) were used to collect data. 
Data analysis
  Cell Quest and FCS Express software (DeNovo Software, 
USA) were used to analyze the data.
Results
Identification of cross-reactive mAbs that recognize 
conserved epitopes expressed on orthologous LDM 
in rabbits
  At the initiation of the study, we screened sets of mAbs we 
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pigs, cats, and dogs for mAb that cross reacted with rabbit 
LDM. We also screened additional sets of mAbs we developed 
during the course of the study for cross reactivity. Several 
strategies were used to increase the potential of generating 
mAbs that react with conserved determinants. These included 
hyperimmunization with leukocytes from multiple species 
and then selecting a single species to screen supernatants 
from primary cultures of freshly prepared hybridomas, 
hyperimmunization with leukocytes from a single species 
and screening for mAbs reactive with leukocytes from 
another species of interest, hyperimmunizing with leukoc-
ytes from a single species and screening for all mAbs that 
reacted with LDM from the same species and then 
screening for cross reactivity with LDM in other species. 
Although not used extensively for identification of cross 
reactive mAbs, simultaneous examination of primary 
cultures for mAb that recognized epitopes conserved on 
LDM in two species, using hydroethidine to mark one set 
of cells, showed that cross reactive mAbs could be 
identified directly. Cross reactive mAbs to bovine, caprine, 
and ovine CD4, CD8, CD45R, and CD45R0 were identified 
by this method [11,28]. Regardless of the strategy used for 
immunization, the most frequently encountered cross reactive 
mAbs were specific for MHC class I and II molecules. 
Other mAbs of interest that were identified by single 
fluorescence analysis recognized epitopes only conserved 
on orthologous molecules in closely related species e.g.: 
epitopes conserved on orthologous LDM in bison, water 
buffalo, Cape buffalo, goats, and sheep, with highest con-
servation noted between orthologues in cattle and bison 
[43]. Some of the epitopes recognized by mAbs were 
highly conserved and expressed on LDM in closely and 
distantly related species[12,54] (Table 1). 
  The screening of several hundred mAbs developed in our 
laboratory yielded 13 mAbs that recognize conserved 
epitopes expressed on rabbit LDM. The specificity of 10 of 
the mAbs (RH1A and LT86A [CD9]; HUH73A [CD11a]; 
CAM36A [CD14]; H20A, BAQ30A, and HUH82A [CD18]; 
and BAG40A and LT41A [CD44] ) was validated in the 
Animal Homologues section of the HLDA8 (Table 1, Fig. 
1) [12,54]. Two additional mAbs, RACT48A and GBSP71A 
submitted to the workshop reacted with molecules expres-
sed on multiple lineages of leukocytes in humans and other 
species. No clear match was obtained with standard panels 
of human leukocytes or cell lines transfected with known 
CD molecules. BAQ44A and CADO34A were not sub-
mitted to the HLDA8 workshop since they did not react 
with leukocytes from humans. However, the mAb-defined 
epitope recognized by BAQ44A is expressed on B 
lymphocytes in multiple species of ruminants. The epitope 
recognized by CADO34A is expressed on granulocytes, B 
lymphocytes and subsets of T lymphocytes in dogs and 
cats. Multiple mAbs were identified that reacted with 
rabbit MHC I and II molecules. The best characterized 
mAbs are listed in Table 1. Analysis of the specificities of 
TH14B and TH81A5 have shown they recognize epitopes 
conserved on the orthologues of HLA-DR and HLA-DQ, 
respectively [1].
Identification of mAbs that recognize LDM expressed 
on T lymphocytes
  Screening of the mAb sets obtained from the different 
fusions yielded multiple mAbs that recognize LDM 
expressed on all lymphocytes or subsets of lymphocytes. 
These were further analyzed to determine which mAbs 
detected LDM expressed on T lymphocytes, B lymp-
hocytes, or T and B lymphocytes using 2 color FC. 
Fluorescein conjugated anti-rabbit Ig was used to identify 
mAbs recognizing LDM on B lymphocytes. Ken4 (CD4) 
and Ken5 (pan T) were used to identify mAbs recognizing 
LDM on T lymphocytes. 12.C7 (CD8) was used to verify 
specificity of mAbs reacting with CD8 [18]. As summarized 
in Tables 1 and 2 and fig. 1A, 1B, 8 mAbs were identified 
that recognize LDM expressed on all T lymphocytes 
(MRB61A, RT22A, RTH2A, RTH21A, RTH26A, RTH65A, 
RTH230A, and RACT53A). Cross comparison of the 
patterns of reactivity of the mAbs using 2 color FC showed 
RTH2A and RTH230A; RT21A and RTH21A; and RTH26A, 
RTH65A, and Ken5; recognize Pan T1, Pan T2, and Pan T4 
LDM respectively. Zenon second step antibodies were 
used to demonstrate RTH2A (IgG1) and RTH230A (IgG1) 
recognize the same LDM (Fig. 2). RACT53A (PanT5) 
recognizes an additional molecule expressed on all T cells 
(Fig. 3). Analysis of the reactivity of MRB61A (Pan T3) 
revealed it detects a LDM expressed on all T lymphocytes 
and basophils (Fig 1 #7, two color labeling not shown).
  Seven mAbs were identified that recognize LDM expressed 
on T lymphocyte subsets. Comparison of labeling with 
Ken 4 and 12.C7 demonstrated that RTH1A recognizes 
CD4 [41] and that ISC16A, ISC27A, ISC29A, ISC38A, 
and RT1A recognize CD8 [18] (Table 1, Fig. 1 #9 & #10, 
FC two color comparisons not shown). No information was 
obtained on whether the CD8 mAbs recognize epitopes on 
CD8α or CD8β.
  Comparison of labeling with RACT19A (Fig. 1 #12) with 
PanT1, RTH1A and ISC38A revealed the molecule 
detected is expressed on a large subset of CD4 and the 
majority of CD8 lymphocytes (Fig. 4). 
Identification of mAbs that recognize LDM expressed 
on B lymphocytes
    Eleven mAbs were identified that recognize LDM 
expressed on B lymphocytes (Tables 1 and 2, Fig. 1 #16, 
#17 & #18). Comparison of labeling with fluorescein 
conjugated polyclonal anti-rabbit immunoglobulin (Ig), 
RACT30A (Fig. 5) and PanT5 (Fig. 3) were used to 
demonstrate that MRB25, MRB29A, and MRB143A 
recognize one or more molecules expressed on all B Monoclonal antibodies specific for rabbit leukocyte differentiation molecules    55
Table 1. Monoclonal antibodies reactive with rabbit mhc and leukocyte differentiation molecules
    MoAb   Ig isotype Specificity
H1A
H58A
TH14B
TH81A5
RTH2A
RTH230A
RTH21A
RT22A
MRB61A
RTH26A
RTH65A
RACT53A
RTH1A
RTH192A
ISC16A
ISC27A
ISC29E
ISC38A
RT1A
RACT19A
RACT20A
MRB120A
RACT14A
RACT21A
RACT30A
MRB25A
MRB29A
MRB143A
BAQ44A
CADO34A
RT19A
MRB107A
MRB102A
RTH186A
RH1A
LT86A
RACT48A
HUH73A
RTH161A
RT18A
RT3A
CAM36A
H20A
HUH82A
BAQ30A
25-32
BAG40A
LT41A
ISC18A
IgG2a
IgG2a
IgG2a
IgG2a
IgG1
IgG1
IgG1
IgM
IgG1
IgG2a
IgM
IgG1
IgG1
IgG1
IgM
IgG2a
IgG1
IgG1
IgM
IgM
IgG1
IgG1
IgM
IgM
IgM
IgM
IgM
IgM
IgM
IgM
IgM
IgG1
IgM
IgG1
IgG3
IgG2a
IgG1
IgG1
IgG1
IgM
IgM
IgG1
IgG1
IgG2a
IgG1
IgG1
IgG3
IgG2a
IgG2a
MHC CL I
MHC CL I
MHC CL II HLA-DR equivalent
MHC CL II HLA-DQ equivalent (polymorphic determinant)
Pan T1
= Pan T1
Pan T2
= Pan T2 (blocked by RTH21A)
Pan T3 (also expressed on basophils)
Pan T4 = Serotec Ken 5 (diagonal co-labeling)
Pan T4 = RTH26A (diagonal co-labeling)
Pan T5
CD4 = Serotec Ken 4 (diagonal co-labeling)
CD5 (inferred from pattern of FC labeling)
CD8 (diagonal co-labeling with ISC27A, ISC29A, ISC38A) 
CD8 (diagonal co-labeling with12.C7, ISC29A, ISC38A, RT1A)
CD8
CD8
CD8
CD4 and CD8 subpopulations
Basophils and subpopulation of CD4
+ T lymphocytes
Granulocytes, basophils, and monocytes
Subpopulations of B and T lymphocytes
Subpopulations of B and T lymphocytes
Pan B (expressed on some T lymphocytes?)
Pan B
Pan B
Pan B
Pan B and subpopulation of CD4 and CD8 T lymphocytes
Pan B and subpopulation of CD4 and CD8 T lymphocytes
B subpopulation
B subpopulation
Pan lymphocyte
Pan lymphocyte
CD9
CD9
CD11a = Serotec CD11a
CD11a = RACT48A
CD11a = HUH73A = RACT48A
CD11b = Serotec CD11b
CD11c = Serotec CD11c
CD14
CD18
CD18
CD18
CD44
CD44
CD44 = BAG40A
CD45 = Serotec56    William C. Davis et al.
Table 1. Continued
     MoAb     Ig isotype Specificity
ISC39A
ISC76A
ISC4A
ISC24A
RTH32A
RTH33A
RACT43A
RACT44A
RACT38A
RT23A
RACT1A
RACT4A
RACT12A
IgG1
IgM
IgG3
IgM
IgM
IgG1
IgM
IgM
IgG1
IgM
IgG1
IgG1
IgG1
CD45 = ISC18A, ISC76A
CD45 = Serotec CD45 (blocks labeling with Serotec CD45)
Pan T + granulocytes 
Pan T + granulocytes (diagonal with ISC4A)
CD58 = Serotec CD58
CD58 = RTH32A = Serotec CD58
Granulocytes
Granulocytes = RACT43A?
Pan leukocyte
Pan leukocyte
ACT1
ACT2
ACT3
Fig. 1. Representative dot plot profiles of peripheral blood leukocytes labeled with the mAbs indicated. A single representative profile
is shown for mAbs that recognize the same or different epitopes on the same subset of cells. A side light scatter (SSC) vs forward light
scatter dot plot was used to gate and color code the major populations of leukocytes: red for granulocytes, green for monocytes, blue
for basophils, and orange for lymphocytes. Note that in contrast to other species, rabbits have a relatively large population of basophils
in blood. It was necessary to label leukocytes in blood and use a fix lyse solution to isolate and analyze the composition leukocytes in
peripheral blood. T lymphocytes bind to erythrocytes and are lost when leukocytes are separated using density gradient separation 
media.Monoclonal antibodies specific for rabbit leukocyte differentiation molecules    57
Fig. 1. Continued.
Fig. 2. Two color FC analysis of labeling with mAbs that recognize different epitopes expressed on the same molecule. mAbs that 
recognize epitopes on the same molecule yield a diagonal pattern of labeling if the epitopes are sterically distant from each other. If the
mAbs recognize the same epitope or epitopes that are sterically close, labeling with one mAb will block labeling with the second mAb.
RTH2A and RTH230A recognize different epitopes expressed on a molecule expressed on all T lymphocytes.
lymphocytes (dot plots not shown). Comparison of 
labeling of MRB107A with MRB25A and BAQ44A demon-
strated that MRB107A recognizes a LDM expressed on a 
subset of B lymphocytes. The molecule detected is only 
expressed on a subset of MRB25
+ B lymphocytes. The 
whole population is included in the BAQ44A positive 
population of B lymphocytes (Fig. 6). As shown in Table 2, 
the level of expression of the pan B mAb-defined LDM(s) 
were similar in peripheral blood, thymus and spleen. 
However, other mAbs that recognize LDM expressed on 
subsets of B lymphocytes exhibited different patterns of 
expression (Table 2, FC for thymus and spleen not shown). 58    William C. Davis et al.
Fig. 3. Two color FC analysis showing the pattern of labeling obtained with mAbs that recognize different molecules only expressed
on T lymphocytes. The subsets labeled with anti-CD4 and CD8 mAbs are included in the population labeled with a pan T mAb, panels
1 and 2. Labeling with the two anti-pan T mAbs yields a diffuse pattern of labeling, panel 3. Mutually exclusive populations of 
lymphocytes are labeled with mAbs specific for T and B lymphocytes, panel 4. The example presented here suggests a small subset of
B lymphocytes may express the pan T4-defined T lymphocyte molecule.
Fig. 4. Two color FC analysis showing RACT19A recognizes a molecule expressed on a major subset of T lymphocytes, panel 1. mAbs
specific for PanT1, CD4, and CD8 were combined to show the molecule is expressed on a large subset of CD4 T lymphocytes and most
CD8 lymphocytes. The level of expression of the RACT19A-defined molecule on CD4 lymphocytes is less than the level of expression
on CD8 lymphocytes.
Fig. 5. Two color FC analysis demonstrating that RACT30A recognizes a molecule expressed on all B cells, panel 1. As shown in panel
2, immunoglobulin detected with polyclonal anti-rabbit Ig is also present on basophils. RACT20A recognizes a molecule expressed on 
basophils and a subset of CD4 T lymphocytes.
The subset of B lymphocytes detected with RACT14A and 
RACT21A was in low frequency in peripheral blood and in 
high frequency in spleen and appendix. The subset detected 
with RTH72A was low in peripheral blood, thymus, and 
appendix and high in spleen. The subset detected with 
mAbs RT19A and RTH172A was low in peripheral blood 
but high in thymus, spleen, and appendix.
Identification of mAbs that recognize LDM expressed 
on T and B lymphocytes
  Four mAbs were identified that recognize LDM expressed 
on T and B lymphocytes, MRB102A, RTH186A, RTH192A, 
and BAQ44A (a cross reactive mAb) (Fig. 1 #19, #20, #11 
& #15, respectively). The level of expression of the LDM 
detected with MRB102A on lymphocytes was higher than Monoclonal antibodies specific for rabbit leukocyte differentiation molecules    59
Table 2. Reactivity of monoclonal antibodies with leukocyte 
from blood and primary and secondary lymphoid organs
mAb % +
Peripheral blood
%+
Thymus
%+
Spleen
%+
Appendix
H1A
H58A
TH14B
TH81A5
RTH2A
RTH230A
RTH21A
RT22A
MRB61A
RTH26A
RTH65A
RACT53A
RTH1A
RTH192A
ISC16A
ISC27A
ISC29E
ISC38A
RT1A
RACT19A
RACT20A
MRB120A
RACT30A
MRB25A
MRB29A
MRB143A
RACT14A
RACT21A
RT19A
RTH72A
RTH172A
86
82
57
58
27
28
26
27
40
28
26
30
24
50
  4
  4
  4
  4
  4 
  8
18
22
26
14
15
15
9
11
5
3
7
57
46
63
52
37
37
92
97
99
99
99
28
87
16
83
84
75
86
84
6
2
1
11
10
6
5
14
13
50
8
59
79
75
50
47
37
40
45
44
45
48
36
59
20
57
9
12
9
9
10
15
4
6
45
44
45
38
45
48
45
31
44
8
7
99
99
4
4
4
4
8
5
5
11
3
97
1
1
1
1
1
13
3
20
94
82
77
77
69
69
56
5
61
Table 2. Continued
mAb % +
Peripheral blood
%+
Thymus
%+
Spleen
%+
Appendix
MRB107A
MRB102A
RTH186A
BAQ44A
CADO34A
RACT48A
HUH73A
RTH161A
RT18A
RT3A
MRB128A
CAM36A
H20A
HUH82A
BAQ30A
BAG40A
LT41A
ISC18A
ISC39A
ISC76A
ISC4A
ISC24A
ISC26A
ISC36A
ISC90A
RT15A
RTH33A
RACT43A
RACT44A
RACT38A
RT23A
7
38
40
34
12
99
99
99
28
7
8
8
99
99
99
93
99
99
99
99
20
15
34
24
28
33
99
32
27
99
99
4
75
14
40
3
97
NT
99
5
1
2
1
97
NT
99
15
NT
90
NT
NT
49
91
97
98
97
97
96
9
9
99
95
18
69
76
59
64
99
NT
99
53
20
36
5
73
NT
76
85
NT
92
NT
NT
54
48
81
70
82
85
99
26
28
88
95
3
79
8
82
90
99
NT
99
4
4
7
2
99
NT
99
99
NT
97
NT
NT
5
5
52
9
93
87
31
5
5
99
96
Fig. 6. Two color FC analysis of the expression of a molecule detected with MRB107A that is expressed on a subset of B lymphocytes.
The molecule is expressed on a subset of MRB25A+ B lymphocytes, panel 1. All the MRB107A
+ lymphocytes co-express the molecule
detected with BAQ44A, panel 2.60    William C. Davis et al.
Fig. 7. Two color FC analysis of the expression of RTH192A on T and B lymphocytes. The level of expression of PanT4 on RTH192A
+
lymphocytes was variable from high to low, panel 1. Expression of CD4 and the MRB25A-defined B molecule were also low, panels
2 and 4. Expression of the TH192A-defined molecule was invariably higher on CD8 lymphocytes than expression on the other 
mAb-defined populations, panel 3.
Fig. 8. Two color FC analysis of the expression of BAQ44A- and CADO34A-defined molecules. The BAQ44A-defined molecule was
not expressed on granulocytes or monocytes. Comparison of labeling with BAQ44A in combination with mAbs to PanT1, CD4, and 
CD8 showed subsets of CD4 and CD8 co-expressed the BAQ44A-defined molecule, panel 2. The molecule was not expressed on 
basophils, panel 4. The pattern of labeling indicate a subset of Pan T
+ CD4
-, CD8
- also express the BAQ44A-difined molecule. B cells
also co-expressed the molecule. The molecule was not expressed on basophils, panel 3. A similar pattern of labeling was observed with
the CADO34A-defined molecule, Panels 2 and 3. The molecule was also expressed on granulocytes, panel 1.
the LDM detected with RTH186A. However, two color 
analysis showed the level of expression of both LDMs on 
CD4 and CD8 T and B lymphocyte subsets was similar (FC 
not shown). The level of expression of the MRB102A- 
defined LDM was also high on lymphocytes in the thymus, 
spleen, and appendix. In contrast, the RTH186A defined 
LDM was only expressed on a few lymphocytes in the thymus 
and appendix. It was expressed on a large population of 
lymphocytes in the spleen (Table 2, FC not shown).
    The level of expression of the LDM detected with 
RTH192A and BAQ44A differed on CD4 and CD8 T and 
B lymphocytes. The level of expression of the RTH192A- 
defined LDM was variable on PanT 1
+ lymphocytes (Fig. 
7). It was low on CD4 T and B lymphocytes (Fig. 7). It was 
high on CD8 T lymphocytes (Fig. 7). It was only expressed 
on a few thymocytes. It was expressed at a high level on 
about 50% of lymphocytes in the spleen and essentially all 
lymphocytes in the appendix (Table 2, FC not shown). The 
pattern of expression on T and B lymphocytes suggests the 
LDM detected is CD5 [41,49-51].
  The level of expression of the LDM detected with BAQ44A 
also differed on CD4 and CD8 T and B lymphocytes (Fig. 
8). Simultaneous labeling with Pan T1, CD4, and CD8 
mAbs and anti-rabbit Ig demonstrated that the LDM is Monoclonal antibodies specific for rabbit leukocyte differentiation molecules    61
Fig. 9. Two color analysis of the expression of LDM detected with RACT20A and MRB120A on basophils, monocytes, and CD4 T 
lymphocytes.  mAbs to CD14 and Pan T1 were combined and used to distinguish monocytes and T lymphocytes simultaneously. 
MRB102A was used to identify all T and B lymphocytes.  Polyclonal anti-Ig was used to distinguish B lymphocytes.  Panel 1 shows
the populations present in PBMC: basophils, lower left quadrant; monocytes, upper left quadrant; T lymphocytes, upper right quadrant;
B lymphocytes, lower right quadrant.  Panel 2 shows the LDM recognized by RACT20A is only expressed on basophils, upper right
quadrant.  As noted, Ig is present on basophils.  Panel 3 shows the LDM recognized by MRB120A is expressed on monocytes, upper 
left quadrant and basophils, upper right quadrant.  Panel 4 shows the LDM recognized by RACT20A is expressed on basophils, lower
right quadrant and also a subset of CD4 T lymphocytes, upper right quadrant.
highly expressed on B lymphocytes, a subset of CD4 and 
CD8 negative T lymphocytes, a large subset of CD4 T 
lymphocytes and the majority of CD8 T lymphocytes. The 
BAQ44A-defined LDM was expressed on large popula-
tions of lymphocytes in the thymus, spleen and appendix 
(Table 2, FC not shown).
Identification  of  a  mAb  that  recognizes  a  LDM 
expressed on granulocytes, T and B lymphocytes
  One cross reactive mAb, CADO34A, was identified that 
recognizes a LDM expressed on granulocytes as well as T 
and B lymphocytes (Fig. 8). Comparison of labeling with 
CADO34A to labeling with BAQ44A revealed the pattern 
of labeling is similar to the labeling pattern obtained with 
BAQ44A for T and B lymphocytes. Simultaneous labeling 
with Pan T1, CD4, and CD8 mAbs demonstrated the LDM 
is expressed on a subset of CD4 and CD8 negative lymphoc-
ytes, a large subset of CD4 and the majority of CD8 T 
lymphocytes. The LDM was only expressed on a few 
thymocytes. It was expressed on a large population of 
lymphocytes in the spleen and most of the lymphocytes in 
the appendix (Table 2, FC not shown).
I d e n t i f i c a t i o n  o f  a  m A b s  t h a t  r e c o g n i z e  a  L D M  e x -
pressed on granulocytes and monocytes, granulocytes, 
monocytes and basophils, or basophils
  Three mAb were identified that detect LDM expressed on 
granulocytes and monocytes, granulocytes, monocytes 
and basophils or basophils (CAM36A, MRB120A, and 
RACT20A, Fig. 1 #26, #22 & #13, respectively and Fig. 9). 
CAM36A recognizes a conserved epitope expressed on 
CD14. In contrast to some species, expression of CD14 is 
high on rabbit granulocytes. Two color analyses showed 
CD14 is not expressed on basophils (Fig. 9). Two color 
analyses showed the MRB120A recognizes a LDM 
expressed on granulocytes, monocytes and basophils while 
the RACT20A recognizes a LDM only expressed on 
basophils and a subset of CD4
+ lymphocytes (Fig. 9). 
Expression on CD8 lymphocytes is low or absent. Two 
color analyses were not performed to determine whether 
expression of the RACT20A-defined LDM on small 
populations of cells detected in the thymus, spleen and 
appendix were basophils or T lymphocytes (Table 2).
Identification of mAbs recognizing LDM expressed 
on granulocytes
  Two mAbs (RACT43A and RACT44A Table 1, Fig. 1 
#36) were identified that recognize a LDM expressed on 
granulocytes. The similarity of the pattern of labeling with 
the mAbs suggests they may recognize the same LDM.
Identification of mAbs recognizing CD9
  Comparison of the labeling patterns with cross reactive 
RH1A and LT86A (Table 1, Fig. 1 #21) showed they 
recognize CD9 in rabbits. 
Identification of mAbs recognizing CD11a, CD11b, 
CD11c, and CD18
  mAbs that recognize CD11a, CD11b, CD11c, and CD18 
(Table 1, Fig. 1 #23, #24, #25 & #27 respectively) were 
identified by two color FC with mAbs that recognize 
epitopes conserved on orthologues in one or more species 
or with commercially available mAbs generated against 
the rabbit orthologues. Comparison of the patterns of 
labeling obtained with RACT48A and RTH161A with 
commercially available anti-CD11a (Ken11) [31] suggested 
these mAbs recognize CD11a. Subsequent comparative 
two color FC analysis with HUH73A, a mAb demonstrated 
to recognize a conserved epitope on the CD11a orthologue 
in the Animal Homologues section of the HLAD8 workshop 
[54], verified these mAbs recognize CD11a (Fig. 10). The 
studies also demonstrated RTH161A recognizes a species 
restricted epitope. Comparison of the patterns of labeling 
obtained with RT18A with anti-CD11b (198) and subsequent 62    William C. Davis et al.
Fig. 10. Two color analysis of HUH73A and MRB161A. The similarity in the pattern of labeling obtained with both mAbs indicates 
they recognize the same molecule, panels 1 and 2. The diagonal pattern of labeling indicates the mAbs recognize epitopes on the same
molecule. Based on findings with HUH73A in the animals homologues section of the 8th human leukocyte antigen workshop, the 
molecule identified is the rabbit orthologue of CD11a. 
2 color FC showed RT18A recognizes CD11b (Fig. 1 #24). 
Similar studies comparing RT3A with 3/22 showed RT3A 
recognizes CD11c (Fig. 1 #25). Three mAbs demonstrated 
to recognize conserved epitopes on orthologues of CD18 
(Fig. 1 #27), in 2 or more species were shown to recognize 
rabbit CD18. The pattern of expression of the rabbit 
orthologues for each molecule was similar to that noted in 
other species.
Identification of mAbs that recognize CD44, CD45, 
and CD58
  Screening of a large series of mAbs that recognize conserved 
epitopes on CD44 in 2 or more species, including humans, 
showed 25-32 [40], BAG40A, and LT41A (Table 1, Fig. 1 
#28) recognize epitopes expressed on rabbit CD44 
[14,24,54]. The pattern of expression of rabbit CD44 was 
similar to that noted in other species. Comparison of the 
pattern of labeling obtained with L12/201 (CD45) with the 
panels of mAbs developed against rabbit LDM revealed 
several mAbs yielded similar patterns of labeling (Table 1, 
Fig. 1 #29). Two color flow cytometry yielded diagonal 
patterns of labeling or blocking, indicating the mAbs 
recognize rabbit CD45 (FC not shown). Comparison of the 
labeling pattern obtained with VC21 (CD58) revealed two 
mAbs (RTH32A, RTH33A, Table 1, Fig. 1 #30) yielded 
similar patterns of labeling. Two color comparisons 
yielded diagonal patterns of labeling indicating the mAbs 
recognize CD58 (FC not shown).
Identification of mAbs that recognize LDM expressed 
on granulocytes and lymphocytes
  Six mAbs were identified that recognize LDM expressed 
on granulocytes and lymphocytes ISC4A, ISC24A, ISC26A, 
ISC36A, ISC90A, and RT15A (Table 1, Fig. 1 #31, #26, 
#36, #90 and #35). Two color analysis showed ISC4A and 
ISC24A recognize the same molecule (FC not shown). The 
others identified different molecules. The molecules 
identified with ISC90A and RT15A are also expressed on 
some monocytes. The molecule identified with RT15A is 
highly expressed on thymocytes, spleen lymphocytes, and 
lymphocytes in the appendix (Table 2). Two color analysis 
with anti-CD4 and -CD8 mAbs indicate none of the mAbs 
recognize CD45R0. The studies completed thus far 
indicate there are no clearly defined subsets of CD4 and 
CD8 negative for these LDM (FC not shown). 
Identification of mAbs that recognize LDM expressed 
on all leukocytes 
  Three mAbs under investigation identify LDM expressed 
on all leukocytes RACT38A, RT23A, and GBSP71A (Table 1, 
FC not shown). Comparison of the flow cytometric 
profiles with those of known CD molecules has thus far not 
suggested which molecules are recognized by these mAbs. 
Identification of mAbs that recognize LDM expressed 
on activated lymphocytes
    Three mAbs were identified that recognize mAbs 
upregulated on ConA activated lymphocytes RACT1A, 
RACT4A, RACT12A (Table 1, Fig. 1 #38, #39 & #40). 
Two color analysis with mAbs specific for ConA and 
CD25 [32] demonstrated the mAbs recognize different 
LDM (FC not shown).
Discussion 
  Cumulative data obtained from international workshops 
convened to complete characterization of mAbs to LDM in 
humans have shown flow cytometry can be used to 
compare and cluster mAbs that appear to recognize the 
same LDM for further analysis [34]. Our studies and 
studies conducted as part of workshops convened to 
characterize mAb-defined LDM in ruminants, swine, 
horses, and dogs have shown that the pattern of expression 
of many orthologous of CD molecules is conserved cross 
species [11]. These findings have afforded an opportunity 
to devise a strategy for characterizing mAb to LDM in Monoclonal antibodies specific for rabbit leukocyte differentiation molecules    63
additional less well studied species. mAb that identify 
LDM with patterns of expression similar to the patterns of 
expression of known Human Cell Differentiation Molecules 
(HCDM) can be clustered for further analysis. The TKP 
can be used to facilitate determining whether a mAb 
recognizes a new or known HCDM where flow cytometric 
data are not conclusive. Where cross reactive mAbs are 
identified, they can be used to validate the specificity of the 
mAbs recognizing species restricted epitopes using two 
color FC. A diagonal pattern of labeling implies the 
epitopes detected are present on the same molecule. 
Complete or partial blocking of labeling with one of the 
mAbs indicates the epitopes detected are sterically close on 
the same molecule, with the binding of one mAb 
interfering with the binding of the second mAb. These 
methods of analysis have been used effectively to develop 
a set of mAbs for use in alpacas and llamas [14] and, as 
demonstrated in the present report, rabbits. Cross reactive 
mAbs allowed us to identify mAbs specific for MHC class 
I and II and several CD molecules early in the course of the 
studies. Two color analyses with commercially available 
mAbs to some rabbit LDM facilitated validation of the 
specificity of additional mAbs generated in our laboratory. 
To date, we have identified mAbs to MHC class I and II 
molecules and 16 known LDM. Additional mAbs to T and 
B lymphocytes have been identified that require further 
characterization to determine their relation to known 
mAb-defined HCDM. 
  Until now the lack of mAbs to rabbit LDM and MHC has 
made it difficult to compare the immune system of rabbits 
to those characterized in other species. Comparative studies 
have shown the immune systems of different orders and 
species of vertebrates are similar but not identical. Differences 
have been noted in the evolution and expression of 
immunoglobulin genes with expansion of the IgA genes a 
unique feature of rabbits [41] and the development of IgG 
heavy chain genes a unique feature of camelids [21,41]. 
The expression of αβ CD4 and CD8 T cell subsets have 
appeared similar with an exception in swine. There is a 
large population of CD4/CD8 double positive cells in 
peripheral blood. Analysis has shown the proportion of 
double positive cells increases with age and is correlated 
with the appearance of the majority of memory T cells in 
this population [67,68]. The most striking difference noted 
is in the abundance of γδ T cells in some species [20]. γδ T 
cells comprise a high proportion of lymphocytes in 
peripheral blood of chickens [5,9], swine [2,3,17] and 
ruminants [19,25,39]. The relation between the large 
population of γδ T cells that have evolved in chickens and 
the one in pigs and ruminants is not clear. However, recent 
studies have provided an explanation for the abundance in 
the latter species. Abundance is attributable to the presence 
of a unique subset of γδ T cells that has only been found in 
artiodactyla. The subset is characterized by the expression 
of a molecule referred to as workshop cluster 1 (WC1) in 
ruminants [42]. The WC1
+ population may comprise 50% 
or more of T lymphocytes in the blood of young ruminants 
[62,63]. A WC1- population is also present but comprises 
~5% of γδ T cells in blood [10]. The large subset identified 
in swine expresses the orthologue of WC1 [7,17]. The 
subset expressing the orthologue has been identified in 
camelids also [14].
  An additional difference noted in the comparative studies 
is in the expression of MHC II. In humans, mice, and ruminants 
MHC II is expressed primarily on monocytes and B 
lymphocytes in blood. MHC II is upregulated on T cells 
following activation. MHC II is expressed on monocytes, 
B cells and resting T cells in horses [37], swine [48], dogs 
[8], and cats (personal observation).
  As mentioned, the flow cytometric approach to identifying 
and characterizing mAbs to rabbit LDMs has shown the 
pattern of expression of rabbit orthologues of known 
hCDLDMs have proven, thus far, to be similar. The com-
position of lymphocyte subsets also appear more similar to 
that of humans than ruminants and swine. Analysis of T 
lymphocytes in the rabbit shows αβ T cells are the major 
population present in blood. Comparison of the percen-
tages of cells expressing LDM present on all T cells with 
subsets of cells expressing CD4 or CD8 in two color flow 
cytometry has not revealed any CD4 CD8 double negative 
subset. Likewise comparison of the percentages of 
lymphocytes expressing LDM on T cells with those 
expressing LDM on B cells has not revealed the presence 
of a clearly defined subset of lymphocytes negative for T or 
B cell LDM. The findings suggest γδ T cells comprise a 
small percentage of lymphocytes in blood. Further studies 
are needed to identify rabbit γδ T cells. 
  The unique differences that have been noted are with the 
expression of MHC II on granulocytes, expression of 
certain mAb-defined LDM, and presence of immuno-
globulin on basophils. Multiple mAbs of different isotype 
to MHC II were used to confirm expression of MHC II on 
granulocytes. Both IgG1 and IgG2a isotype mAbs yielded 
identical patterns of labeling. As in humans and mice, 
expression of MHC II on monocytes and B cells is similar. 
It is upregulated on activated T cells. Basophils comprise 
5% to 30% of blood leukocytes in rabbits. Two mAbs were 
identified that identify molecules expressed on all T cells 
and basophils (MRB61A) and basophils and a subset of 
CD4 T cells (RACT20A). No information has been 
obtained on the functional activity of these LDM. Two 
color analyses have demonstrated that immunoglobulin is 
present on basophils. This finding is in agreement with an 
earlier study demonstrating the presence of multiple 
immunoglobulin isotypes on basophils, presumably binding 
to basophils through Fc receptors [6].
  In summary, the use of flow cytometry has provided an 
approach to the identification and characterization of 64    William C. Davis et al.
mAbs to MHC I and MHC II molecules and LDM in less 
well studied species. mAbs that recognize the same LDM 
can be clustered based on the similarity of the pattern of 
expression and further characterized by comparing the 
pattern of expression with that of known LDM. When 
available, identity can be verified by comparison with a 
mAb that recognizes a conserved epitope on orthologous 
molecules. Where needed, mAb cluster-defined LDM can 
be subjected to immunoprecipitation and micro sequencing. 
We have used this approach successfully when partici-
pating in the international workshops of LDM in ruminants 
[26,27,46], swine [23,38,53], horses [33,36], dogs [8], the 
homologues section of the HLDA8 [54,66] and indepen-
dently in the characterization of mAbs to LDM in lamas 
[14] and rabbits. The mAbs characterized here should 
facilitate characterization of the immune system in rabbits 
and the use of rabbits in immunological investigations.
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